Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for MDxHealth SA (MDXH : NSDQ)

• Company Description    MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium. Number of Employees: 312

• Price / Volume Information    Yesterday's Closing Price: $2.21 Daily Weekly Monthly 20 Day Moving Average: 67,208 shares Shares Outstanding: 47.29 (millions) Market Capitalization: $104.51 (millions) Beta: 1.31 52 Week High: $3.50 52 Week Low: $1.35 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.45% -3.90% 12 Week 53.47% 25.21% Year To Date -6.75% -11.61%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL CAP Business Center Rue d`Abhooz 31 Zone Industrielle des Hauts-Sarts - Herstal,C9 4040 BEL ph: 949-812-6979 fax: 949-788-0014 ir@mdxhealth.com https://mdxhealth.com

• General Corporate Information    Officers Michael K. McGarrity - Chief Executive Officer and Executive Director Koen Hoffman - Chairperson Ron Kalfus - Chief Financial Officer John Bellano - Chief Commercial Officer Lieve Verplancke - Director Peer Information MDxHealth SA (HLIS) MDxHealth SA (AZTA) MDxHealth SA (APYI) MDxHealth SA (RNVA) MDxHealth SA (HMSY) MDxHealth SA (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: B5950S113 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/20/25 Share - Related Items Shares Outstanding: 47.29 Most Recent Split Date: 11.00 (0.10:1) Beta: 1.31 Market Capitalization: $104.51 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.13 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.52 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/20/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 17.51 Price/Cash Flow: - Price / Sales: 1.11 EPS Growth vs. Year Ago Period: 38.71% vs. Previous Quarter: -35.71% Sales Growth vs. Year Ago Period: 22.48% vs. Previous Quarter: -1.81% ROE 06/30/25 - - 03/31/25 - -492.11 12/31/24 - -634.36 ROA 06/30/25 - - 03/31/25 - -23.00 12/31/24 - -24.66 Current Ratio 06/30/25 - - 03/31/25 - 2.00 12/31/24 - 1.57 Quick Ratio 06/30/25 - - 03/31/25 - 1.92 12/31/24 - 1.48 Operating Margin 06/30/25 - - 03/31/25 - -37.74 12/31/24 - -38.83 Net Margin 06/30/25 - - 03/31/25 - -41.02 12/31/24 - -42.28 Pre-Tax Margin 06/30/25 - - 03/31/25 - -40.47 12/31/24 - -41.85 Book Value 06/30/25 - - 03/31/25 - 0.13 12/31/24 - 0.31 Inventory Turnover 06/30/25 - - 03/31/25 - 9.37 12/31/24 - 9.28 Debt-to-Equity 06/30/25 - - 03/31/25 - 13.81 12/31/24 - 3.93 Debt-to-Capital 06/30/25 - - 03/31/25 - 93.25 12/31/24 - 79.73

Powered by Zacks Investment Research ©